JP2013500984A - ダプソンとアダパレンの組み合わせ - Google Patents

ダプソンとアダパレンの組み合わせ Download PDF

Info

Publication number
JP2013500984A
JP2013500984A JP2012523029A JP2012523029A JP2013500984A JP 2013500984 A JP2013500984 A JP 2013500984A JP 2012523029 A JP2012523029 A JP 2012523029A JP 2012523029 A JP2012523029 A JP 2012523029A JP 2013500984 A JP2013500984 A JP 2013500984A
Authority
JP
Japan
Prior art keywords
composition
adapalene
dapsone
inflammatory
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012523029A
Other languages
English (en)
Japanese (ja)
Inventor
ガープリート・アールウォリア
ケビン・エス・ワーナー
チェン・ハイガン
ヤン・メイドン
ジェフリー・アール・アーハート
フレデリック・シー・ベディングフィールド
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of JP2013500984A publication Critical patent/JP2013500984A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
JP2012523029A 2009-07-30 2010-07-29 ダプソンとアダパレンの組み合わせ Pending JP2013500984A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22990309P 2009-07-30 2009-07-30
US61/229,903 2009-07-30
PCT/US2010/043671 WO2011014627A1 (en) 2009-07-30 2010-07-29 Combination of dapsone with adapalene

Publications (1)

Publication Number Publication Date
JP2013500984A true JP2013500984A (ja) 2013-01-10

Family

ID=42953716

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012523029A Pending JP2013500984A (ja) 2009-07-30 2010-07-29 ダプソンとアダパレンの組み合わせ

Country Status (6)

Country Link
EP (1) EP2459172A1 (ru)
JP (1) JP2013500984A (ru)
AU (1) AU2010278915A1 (ru)
CA (1) CA2769640A1 (ru)
RU (1) RU2012104572A (ru)
WO (1) WO2011014627A1 (ru)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016136925A1 (ja) * 2015-02-27 2016-09-01 マルホ株式会社 皮膚用組成物
JP2017128555A (ja) * 2016-01-18 2017-07-27 基嗣 田島 ケミカルピーリング剤
WO2019240290A1 (ja) * 2018-06-16 2019-12-19 ロート製薬株式会社 外用組成物
JP2019218345A (ja) * 2018-06-16 2019-12-26 ロート製薬株式会社 外用組成物
JP2020527607A (ja) * 2017-07-21 2020-09-10 アルミラール・リミテッド・ライアビリティ・カンパニーＡｌｍｉｒａｌｌ， Ｌｌｃ 非炎症性病変の処置

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110117182A1 (en) * 2009-07-30 2011-05-19 Allergan, Inc. Combination of dapsone with other anti-acne agents
EP2563357B1 (en) * 2010-04-29 2018-10-17 Galderma Research & Development Adapalene 0.3% for use in a method for treating scars
AU2012223245A1 (en) * 2011-03-03 2013-09-19 Allergan, Inc. Non-aqueous silicone-based ophthalmic formulations
RU2014102494A (ru) 2011-06-30 2015-08-10 Аллерган, Инк. Ретиноидные композиции местного применения и способы лечения состояний кожи
BR112015011673B1 (pt) 2012-11-20 2021-03-09 Allergan, Inc. composição e uso da mesma

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030157036A1 (en) * 2002-02-20 2003-08-21 Osborne David W. Topical dapsone for the treatment of acne
KR20070091613A (ko) * 2004-11-08 2007-09-11 그렌마크 파머수티칼스 엘티디. 항여드름 화합물 및 항생제 화합물을 함유하는 국소적 제약조성물
MXPA06008988A (es) * 2006-08-08 2008-02-07 Fernando Ahumada Ayala Preparaciones topicas antiacne que contienen retinoide (tazaroteno o adapaleno), antibiotico (fosfato de clindamicina) y/o queratolitico (peroxido de bonzoilo en microesponjas).
US20100029781A1 (en) * 2008-06-04 2010-02-04 Morris Jerome A Methods for preparation of anti-acne formulation and compositions prepared thereby

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016136925A1 (ja) * 2015-02-27 2016-09-01 マルホ株式会社 皮膚用組成物
JPWO2016136925A1 (ja) * 2015-02-27 2017-12-07 マルホ株式会社 皮膚用組成物
JP2017128555A (ja) * 2016-01-18 2017-07-27 基嗣 田島 ケミカルピーリング剤
JP2020527607A (ja) * 2017-07-21 2020-09-10 アルミラール・リミテッド・ライアビリティ・カンパニーＡｌｍｉｒａｌｌ， Ｌｌｃ 非炎症性病変の処置
WO2019240290A1 (ja) * 2018-06-16 2019-12-19 ロート製薬株式会社 外用組成物
JP2019218345A (ja) * 2018-06-16 2019-12-26 ロート製薬株式会社 外用組成物
JPWO2019240290A1 (ja) * 2018-06-16 2021-06-24 ロート製薬株式会社 外用組成物
JP7299766B2 (ja) 2018-06-16 2023-06-28 ロート製薬株式会社 外用組成物

Also Published As

Publication number Publication date
AU2010278915A1 (en) 2012-03-01
RU2012104572A (ru) 2013-09-10
WO2011014627A1 (en) 2011-02-03
EP2459172A1 (en) 2012-06-06
CA2769640A1 (en) 2011-02-03

Similar Documents

Publication Publication Date Title
JP2013500984A (ja) ダプソンとアダパレンの組み合わせ
US10688117B2 (en) Topical wash composition for use in acne patients
US8679552B2 (en) Acne vulgaris treatment regimen
US20110117182A1 (en) Combination of dapsone with other anti-acne agents
US8293790B2 (en) Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
US10028972B2 (en) Pharmaceutical compositions of anti-acne agents
US20130131177A1 (en) Use of a dermatological composition comprising a combination of adapalene and benzoyl peroxide which is intended for the treatment of acne in non-caucasian population with decrease of post-inflammatory hyperpigmentation
EP2167062B1 (en) Compositions and uses comprising a retinoid compound, an anti-irritant compound and benzoyl peroxide in acne
US20100068284A1 (en) Stable Fixed Dose Topical Formulation
EP3411014B1 (en) New topical compositions comprising usnic acid and their use in therapy
AU2008209730B2 (en) Use of adapalene and benzoyl peroxide for the long term treatment of acne vulgaris
JP5275811B2 (ja) 少なくとも１種のレチノイド化合物と、少なくとも１種の抗刺激剤化合物とを含む組成物およびその使用
US20130337016A1 (en) Method for treatment of acne using pharmaceutical compositions of clindamycin and adapalene
US20110305747A1 (en) Combination of dapsone with other anti-acne agents
WO2012053010A2 (en) Method for treatment of acne using pharmaceutical compositions of clindamycin
SG176097A1 (en) Topical retinoid solutions
WO2022140467A1 (en) Topical compositions and methods of treating skin diseases and conditions with such compositions
WO2019190435A2 (en) The combination comprising adapalene, benzoyl peroxide and an agent from the cicatrizant group
TR201606979A1 (tr) Topi̇kal terapöti̇k formülasyonlar
CA2963110A1 (en) Method of administration of chromium and magnesium sulfate for treatment of acne